Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Midland States Bancorp, Inc.MSBI · Entity 5253 | Director | September 30, 2020 | October 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Midland States Bancorp, Inc.
Report date September 30, 2020 · Filed October 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Share EquivalentSEC Table II · derivative / convertible security | Direct | 69,642.0008 |
Reported balance
After 2020-09-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-09-30 · Grant · Acquired 869.4747 · Balance 69,642.0008 F3: Each common stock equivalent is the economic equivalent of one share of common stock. F4: Represents common share equivalents acquired by the reporting person under the Issuers Directors Deferred Compensation Plan (DDCP) with respect to director fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees fully vested on the transaction date listed above and become payable upon termination of service as a director. |
| Common Share EquivalentSEC Table II · derivative / convertible security | Direct | 71,142.4227 |
Reported balance
After 2020-09-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-09-30 · Grant · Acquired 1,500.4219 · Balance 71,142.4227 F3: Each common stock equivalent is the economic equivalent of one share of common stock. F5: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. |
| Common StockSEC Table I · non-derivative | Direct | 288,426 |
Reported balance
Holding disclosure · report date 2020-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 288,426 F1: Includes holdings through a self-directed IRA or revocable grantor trust |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 2,750 |
Reported balance
Holding disclosure · report date 2020-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,750 F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
| Common StockSEC Table I · non-derivative | IndirectAgracel, Inc. | 42,554 |
Reported balance
Holding disclosure · report date 2020-09-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 42,554 F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
| Common StockSEC Table I · non-derivative | IndirectJNJ, LLC | 69,903 |
Reported balance
Holding disclosure · report date 2020-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 69,903 F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,303 |
Reported balance
Holding disclosure · report date 2020-09-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 3,303 F3: Each common stock equivalent is the economic equivalent of one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes holdings through a self-directed IRA or revocable grantor trust
F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose
F3: Each common stock equivalent is the economic equivalent of one share of common stock.
F4: Represents common share equivalents acquired by the reporting person under the Issuers Directors Deferred Compensation Plan (DDCP) with respect to director fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees fully vested on the transaction date listed above and become payable upon termination of service as a director.
F5: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2016 Filed Oct 3, 2016 22:14 UTC | Midland States Bancorp, Inc. MSBI · Entity 5253 | GrantCommon Share Equivalent · Derivative | 572.2178 | $25.34 | $14,500.00 |
DisclosureSEC source: 0001593968-16-001096 · primary_01.xml · derivative · entry 5 Schultz John M · CIK 0001526231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,109.2341 Underlying: Common Stock · 572.2178 shares Expires not disclosed F3 · derivative.exercise_price: Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above. F4 · derivative.exercise_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. F4 · derivative.expiration_date: Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.